Canada viscosupplementation market set to grow at over 7.5% CAGR through 2033

The prevalence of osteoarthritis in Canada is increasing due to an aging population and higher obesity rates. Viscosupplementation, involving hyaluronic acid injections, is a popular minimally invasive treatment for OA pain.